Cargando…
Pharmacokinetic Interaction Between Fingolimod and Carbamazepine in Healthy Subjects
This open‐label, single‐sequence study in healthy subjects investigated the effects of steady‐state carbamazepine on the pharmacokinetic (PK) profile of a single 2‐mg dose of fingolimod. In period 1, a single oral dose of fingolimod 2 mg (day 1) was followed by PK and safety assessments up to 36 day...
Autores principales: | David, Olivier J., Behrje, Rhett, Pal, Parasar, Hara, Hisanori, Lates, Christian D., Schmouder, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6099239/ https://www.ncbi.nlm.nih.gov/pubmed/29694732 http://dx.doi.org/10.1002/cpdd.459 |
Ejemplares similares
-
Determination of Seminal Concentration of Fingolimod and Fingolimod‐Phosphate in Multiple Sclerosis Patients Receiving Chronic Treatment With Fingolimod
por: David, Olivier J., et al.
Publicado: (2017) -
The Effect of Pioglitazone on Pharmacokinetics of Carbamazepine in Healthy Rabbits
por: Abushammala, Issam
Publicado: (2015) -
A phase 1 study to evaluate the safety, tolerability and pharmacokinetics of TAK‐041 in healthy participants and patients with stable schizophrenia
por: Yin, Wei, et al.
Publicado: (2022) -
Pharmacokinetic and pharmacodynamic drug interactions of carbamazepine and glibenclamide in healthy albino Wistar rats
por: Prashanth, S., et al.
Publicado: (2011) -
Effect of esomeprazole on the pharmacokinetics of carbamazepine
por: Medhi, Bikash, et al.
Publicado: (2011)